Martin Offringa

Update to the PRISMA guidelines for network meta-analyses... : JBI Evidence Synthesis oduction: The PRISMA extensions for NMA and ScRs were published in 2015 and 2018. However, since then, their methodologies and innovations, including automation, have evolved. There is no reporting ...

The objective of this scoping review is to develop a list of items for inclusion in the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) reporting guidelines for network meta-analysis (NMA), scoping reviews (ScRs), and rapid reviews (RRs).
journals.lww.com/jbisrir/full...

02.02.2025 18:12 — 👍 0    🔁 0    💬 0    📌 0

Review of clinical trials and guidelines for children and youth with mucopolysaccharidosis: outcome selection and measurement - Orphanet Journal of Rare Diseases Background To inform the development of a core outcome set (COS) for children and youth with mucopolysaccharidoses (MPS), we aimed to identify all outcomes and associated outcome measurement instrumen...

Outcomes reported in clinical trials and guidelines for MPS in children and youth vary considerably and largely focus on pathophysiological manifestations. A COS is needed to standardize the selection and measurement of meaningful outcomes across future studies ojrd.biomedcentral.com/articles/10....

30.01.2025 17:36 — 👍 1    🔁 0    💬 0    📌 0